TOTAL REVENUE $4,500 $4,700
**GROSS MARGIN approx. 77%
**SG&A approx. 27%
**R&D approx. 17%
Net Interest / Other approx. 60
TAX RATE - GAAP approx. 30%
*TAX RATE - NON-GAAP approx. 31%
GENZ GAAP EPS approx. $2.75
AMORTIZATION approx. $0.55
FAS123 EXPENSE approx. $0.60
CONTINGENT CONVERTIBLE DEBT approx. $0.10
**GENZ NON-GAAP EPS $4.00
***WTD AVERAGE SHARES O/S approx. 274
CAPITAL EXPENDITURES approx. $500
This financial guidance, which is provided as part of a press release
dated February 13, 2008, is subject to all of the qualifications and
limitations described therein. Actual results may differ from these
forward- looking statements due to the numerous factors described in the
*Non-GAAP tax rate excludes the impact of amortization, one-time events,
FIN 46, FAS123 expense and EITF 04-08.
**Non-GAAP excludes the impact of amortization, one-time events, FIN 46,
FAS123 expense and EITF 04-08.
***WTD Average Shares Outstanding excludes the impact of EITF 04-08.
|SOURCE Genzyme Corporation|
Copyright©2008 PR Newswire.
All rights reserved